相关实验视频

Updated: Jan 17, 2026

Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation

Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation

Published on: September 28, 2022

将设计思维方法整合到制药产品开发中:强调纳米医学创新

Aliasgar Shahiwala¹

¹Department of Pharmaceutical Sciences, Dubai Pharmacy College for Girls, Dubai Medical University, Dubai, United Arab Emirates.

Drug development and industrial pharmacy

|September 19, 2025

概括

设计思维 (DT) 通过提供以患者为中心的代方法来增强制药开发. 这种方法加速了纳米医学和药物设计的创新,改善了翻译成功和患者的结果.

科学领域:

制药科学制药科学
生物技术是生物技术.
纳米医学是一种纳米医学.

背景情况:

制药领域的传统研发模式往往是线性的,面临着诸如高消耗率和有限的患者投入等挑战.
设计思维 (DT) 提出了一个以人为中心的,代的替代传统的研发,解决这些局限性.
DT的整合旨在提高将研究转化为可销售产品的成功率.

研究的目的:

批判性地审查设计思维 (DT) 在制药产品开发中的应用.
强调DT在推动纳米医药创新和以患者为中心的药物设计中的作用.
在制药环境中分析DT的五个阶段 (同情,定义,构想,原型,测试).

主要方法:

采用了概念和叙事审查方法.
该审查批判性地审查了DT原则在药物开发中的应用.
分析了成功的纳米医学和药物开发的案例研究.

主要成果:

DT应用产生了诸如同情驱动的设计,有针对性的问题框架和代原型设计等好处.
成功的例子包括Doxil®,ABRAXANE®,mRNA疫苗,CRISPR疗法和细胞外囊泡 (EV) 纳米载体.
DT加速了发展,减轻了风险,并改善了患者和监管的协调.

结论:

将DT整合到制药开发中,可以通过跨学科的合作,降低成本和改进市场翻译来增强创新.
在纳米医学中DT的战略性使用为更安全,更有效的下一代疗法提供了途径.
这种方法使治疗与患者的期望和不断变化的监管环境保持一致.

关键词:

设计思维设计思维创新创新创新创新创新纳米医药是一种纳米医药.制药产品的研发工作.发展原型开发原型

更多相关视频

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

相关概念视频

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...

Biopharmaceutics and Pharmacokinetics: Overview

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...